Evidence map›Paper›PMID 40493193›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Feedback regulation between histone lactylation and ALKBH3-mediated glycolysis regulates age-related macular degeneration pathology.

Ying Wang, Yi-Chen Zhang, Zi-Qin Ding, Shi-Yao Xu, Ye-Ran Zhang, Hong-Jing Zhu, Chang Huang, Jia-Nan Wang, Meidong Zhu, Jiang-Dong Ji and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. mPharmaceuticals (Basel, Switzerland) · 2026
    Review
  5. Review
  6. International journal of ophthalmology · 2026
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ying Wang *Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.ORCID 0009-0007-4004-017X
Yi-Chen Zhang *Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Zi-Qin Ding *Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Shi-Yao Xu *Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.ORCID 0009-0004-9514-2526
Ye-Ran ZhangDepartment of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Hong-Jing ZhuDepartment of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Chang HuangEye Institute and Department of Ophthalmology, Eye, Ears, Nose, and Throat Hospital, Fudan University, Shanghai 200030, China.
Jia-Nan WangDepartment of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Meidong ZhuThe New South Wales Tissue Bank, New South Wales Organ and Tissue Donation Service, Sydney, NSW 2065, Australia.ORCID 0000-0002-1192-0537
Jiang-Dong JiDepartment of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Biao YanDepartment of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
Qing-Huai LiuDepartment of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.
Xue ChenDepartment of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0003-0370-6909

Funding

"333 Project" of Jiangsu Province ("333" Project of Jiangsu Province) NAJiangsu Province Hospital High-level Talent Cultivation Program (Phase I) CZ0121002010037JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation) BK20231371MOST | National Natural Science Foundation of China (NSFC) 82070974MOST | National Natural Science Foundation of China (NSFC) 82271100MOST | National Natural Science Foundation of China (NSFC) 82471096MOST | National Natural Science Foundation of China (NSFC) 82471105Social Development Program of Jiangsu Province BE2022805The Joint Open Research Fund of Suzhou Institute of Nanotechnology and Nano-bionics & Jiangsu Province Hospital and the Medical Engineering Translational Fund of Jiangsu Province Hospital NM202409
6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a leading cause of blindness among the elderly. It is characterized by degeneration of the retinal pigment epithelium (RPE), which can develop into choroidal neovascularization (CNV) to cause severe and rapid vision loss. Preventing this progression might help save vision, but the exact mechanisms remain unclear. In this study, using clinical AMD samples and the gene knockout mice, we reported that the m

Indexed as

AlkB Homolog 3, Alpha-Ketoglutarate-Dependent DioxygenaseGlycolysisHistonesMacular DegenerationAnimalsChoroidal NeovascularizationFeedback, PhysiologicalHumansMiceMice, KnockoutRetinal Pigment EpitheliumVascular Endothelial Growth Factor AAlkB Homolog 3, Alpha-Ketoglutarate-Dependent DioxygenaseHistonesVascular Endothelial Growth Factor Aage-related macular degeneration (AMD)ALKBH3glycolysisN1-methyladenosine (m1A)retinal pigment epithelium (RPE)

Identifiers

PMID40493193
PMCPMC12184506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.